CLINICAL_TRIALS
trial_result
· 2010-02-09
Clinical Trial Update: The Efficacy of a Single Dose of Intranasal Oxytocin in the Prevention of Post Traumatic Stress Disorder (PTSD) [NA]
Summary
A clinical trial evaluating whether a single dose of intranasal oxytocin can prevent post-traumatic stress disorder, but the trial status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sheba Medical Center | Conditions: Stress Disorders, Post-Traumatic | NA | Status: UNKNOWN